Orit Karni-Schmidt

2.6k total citations · 1 hit paper
11 papers, 2.0k citations indexed

About

Orit Karni-Schmidt is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Orit Karni-Schmidt has authored 11 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Orit Karni-Schmidt's work include Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (4 papers) and Epigenetics and DNA Methylation (4 papers). Orit Karni-Schmidt is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Ubiquitin and proteasome pathways (4 papers) and Epigenetics and DNA Methylation (4 papers). Orit Karni-Schmidt collaborates with scholars based in United States, France and United Kingdom. Orit Karni-Schmidt's co-authors include Carol Prives, Michael P. Rout, Svetlana Dokudovskaya, Brian T. Chait, Damien P. Devos, Frank Alber, Andrej Săli, Wenzhu Zhang, Rosemary Williams and Liesbeth M. Veenhoff and has published in prestigious journals such as Nature, Molecular Cell and Molecular and Cellular Biology.

In The Last Decade

Orit Karni-Schmidt

11 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The molecular architecture of the nuclear pore complex

2007 814 citations Frank Alber, Svetlana Dokudovskaya et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Orit Karni-Schmidt United States	11	1.7k	399	235	178	153	11	2.0k
Cynthia S. Hinck United States	17	939 0.6×	197 0.5×	90 0.4×	133 0.7×	118 0.8×	39	1.2k
Erik Bos Netherlands	22	837 0.5×	151 0.4×	184 0.8×	284 1.6×	75 0.5×	44	1.7k
Arvind Rajpal United States	28	1.5k 0.9×	590 1.5×	145 0.6×	45 0.3×	71 0.5×	55	2.7k
Paul S. Uster United States	20	958 0.6×	250 0.6×	58 0.2×	62 0.3×	108 0.7×	31	1.9k
Mai Tran United States	15	1.0k 0.6×	495 1.2×	1.3k 5.3×	71 0.4×	199 1.3×	32	2.3k
Bruno Catimel Australia	26	1.5k 0.9×	488 1.2×	120 0.5×	342 1.9×	29 0.2×	73	2.3k
Borlan Pan United States	15	1.2k 0.7×	311 0.8×	124 0.5×	160 0.9×	107 0.7×	23	1.6k
Michael Blank Israel	25	1.8k 1.1×	257 0.6×	49 0.2×	82 0.5×	70 0.5×	54	2.4k
Tomomi Kubota Japan	24	1.3k 0.7×	138 0.3×	131 0.6×	138 0.8×	150 1.0×	48	1.7k
Radoslav I. Enchev United Kingdom	18	1.3k 0.8×	295 0.7×	28 0.1×	292 1.6×	40 0.3×	21	1.5k

Countries citing papers authored by Orit Karni-Schmidt

Since Specialization

Citations

This map shows the geographic impact of Orit Karni-Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Karni-Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Karni-Schmidt more than expected).

Fields of papers citing papers by Orit Karni-Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orit Karni-Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Karni-Schmidt. The network helps show where Orit Karni-Schmidt may publish in the future.

Co-authorship network of co-authors of Orit Karni-Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Orit Karni-Schmidt. A scholar is included among the top collaborators of Orit Karni-Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orit Karni-Schmidt. Orit Karni-Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Karni-Schmidt, Orit, Maria Lokshin, & Carol Prives. (2016). The Roles of MDM2 and MDMX in Cancer. Annual Review of Pathology Mechanisms of Disease. 11(1). 617–644. 228 indexed citations

2.

Beckerman, Rachel, Andrew Zupnick, Oleg Laptenko, et al.. (2016). Lysines in the tetramerization domain of p53 selectively modulate G1 arrest. Cell Cycle. 15(11). 1425–1438. 14 indexed citations

3.

Gaya, Josep María, Orit Karni-Schmidt, Dennis M. Bonal, et al.. (2014). ΔNp63 Expression is a Protective Factor of Progression in Clinical High Grade T1 Bladder Cancer. The Journal of Urology. 193(4). 1144–1150. 21 indexed citations

4.

Karni-Schmidt, Orit, Mireia Castillo-Martín, Tian Shen, et al.. (2011). Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression. American Journal Of Pathology. 178(3). 1350–1360. 105 indexed citations

5.

Castillo-Martín, Mireia, Josep Domingo‐Domenech, Orit Karni-Schmidt, Tulio Matos, & Carlos Cordon‐Cardo. (2010). Molecular pathways of urothelial development and bladder tumorigenesis. Urologic Oncology Seminars and Original Investigations. 28(4). 401–408. 191 indexed citations

6.

Karni-Schmidt, Orit, Andrew Zupnick, Aqeel Ahmed, et al.. (2008). p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner. Journal of Cell Science. 121(24). 4098–4105. 31 indexed citations

7.

Karni-Schmidt, Orit, Assaf Friedler, Andrew Zupnick, et al.. (2007). Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene. 26(26). 3878–3891. 26 indexed citations

8.

Alber, Frank, Svetlana Dokudovskaya, Liesbeth M. Veenhoff, et al.. (2007). The molecular architecture of the nuclear pore complex. Nature. 450(7170). 695–701. 814 indexed citations breakdown →

9.

Alber, Frank, Svetlana Dokudovskaya, Liesbeth M. Veenhoff, et al.. (2007). Determining the architectures of macromolecular assemblies. Nature. 450(7170). 683–694. 417 indexed citations

10.

Poyurovsky, Masha V., Xavier Jacq, Marie‐Aline Charles, et al.. (2003). Nucleotide Binding by the MDM2 RING Domain Facilitates Arf-Independent MDM2 Nucleolar Localization. Molecular Cell. 12(4). 875–887. 51 indexed citations

11.

Gottifredi, Vanesa, Orit Karni-Schmidt, Sheau-Yann Shieh, & Carol Prives. (2001). p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein. Molecular and Cellular Biology. 21(4). 1066–1076. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact